Industry & Business

Allergan Accelerates Expansion in Ireland With €65 Million Investment

 Breaking News
  • Skillnet Ireland Launches New Network For Small Firms Sector Skillnet Ireland, the national agency responsible for the promotion and facilitation of workforce learning in Ireland, has launched six new networks to address the growing skills needs in the film, television, retail, health and fitness sectors. The six new networks are SFA Skillnet, Screen Skillnet, Leisure, Health & Fitness Skillnet, Fingal Dublin Chamber Skillnet, Dundalk Chamber Skillnet and CSNA Skillnet.  SFA [...]...
  • Circular Economy Leaders, Olleco, Awarded Royal Warrant ABP Food Group’s Renewables Division, Olleco, the UK’s leading supplier of cooking oils and collector of used cooking oils, has become the first dedicated circular economy company to be granted a Royal Warrant by Her Majesty The Queen. The Warrant recognises the company’s work to create a “closed loop” solution for the Royal Household. Olleco supplies [...]...
  • OpenSky to Create 80 Jobs After €2.5 Million Investment in Expansion OpenSky, Ireland’s only GovTech transformation specialist which provides process automated solutions to public sector bodies, has announced that it has invested €2.5 million in its own expansion and will create 80 jobs over the next two years. The company’s employee numbers are set to reach 160 by the end of 2021. New roles will include [...]...
  • Irish-UK Trade Relations to the Fore of Manufacturing Solutions Ireland 2019 Irish-UK trade relations are to the fore of this year’s Manufacturing Solutions Ireland event, as the manufacturing supply chain roadshow and conference, hosted by GTMA* and LIT, has already confirmed more than 100 exhibitors and participants from both sides of the Irish Sea. Now in its third year, the popular event has grown to include [...]...
  • Investigation into Insurance Ireland Data Pooling System The European Commission has opened a formal antitrust investigation into Insurance Ireland to assess whether the conditions of access to its Insurance Link data pooling system may restrict competition, in breach of EU rules. Insurance Ireland is an association bringing together several member companies active in the insurance sector in Ireland. Insurance Ireland administers and makes [...]...

Allergan Accelerates Expansion in Ireland With €65 Million Investment

Allergan Accelerates Expansion in Ireland With €65 Million Investment
May 07
09:09 2019

Global life-science innovation leader, Allergan, which is headquartered in Ireland and operates four facilities here, has announced a €65 million capital investment programme for 2019 to facilitate the continued expansion of the company’s state-of-the art laboratories and manufacturing campuses at Westport in County Mayo and Clonshaugh in north Dublin. The Westport facility has created 63 new highly skilled jobs, bringing total employment in Ireland to more than 2,000 across the country. One in ten employees in Allergan’s global workforce is based in Ireland.

An EY DKM Economic Impact Assessment of Allergan’s operations in Ireland indicates that this 2019 capital investment programme will contribute €23 million to Ireland’s GDP this year and deliver €7 million in exchequer revenue.  In 2018, Allergan generated a GDP impact of €308 million and supported 3,485 jobs in Ireland’s economy, generating exchequer revenue of €76 million.

Allergan’s Westport campus is the largest and most complex in Allergan’s global network. Encompassing a pharmaceuticals facility, two biologics plants and an ocular implant facility, it is responsible for the global supply of flagship Allergan product BOTOX and manufactures a range of eye care products.

Announcing the investment, Paul Coffey, Vice President & Plant General Manager, Allergan Westport, said: “This €65 million investment further cements Ireland’s strategic role in Allergan’s global network. Continued investment of this scale builds on the €50 million investment programme in 2018 and €42 million in 2017 which allows us to apply world-class technology to Allergan’s leading innovation and product development strategy. We are expanding capacity to meet global demand and we are advancing our R&D capabilities to meet the needs of the future for our business. We are proud that 40 years on we are still growing and offering valuable employment opportunities in key regions of Ireland and we thank the communities around us for their continued support.”

The investment in Westport focuses on four key areas; two new manufacturing suites in its biologics facility to provide the capability to introduce new product formats for one of Allergan’s flagship products and the launch of a new product currently in development, as well as the completion of a new state-of-the-art microbiology and cell-based laboratory. The completion of the new Biologics facility – which represents a total investment of more than €140 million – is in the final stages of qualification and regulatory approval before commencing commercial production.

At its ocular implant facility in Westport, Allergan is introducing automated manufacturing processes using high-end robotics.  This new technology could be used to produce products that have the potential to revolutionise the treatment of common eye conditions such as glaucoma. The company is also upgrading its existing manufacturing capabilities and capacity for the introduction of new eye care products due to launch in the coming years.

Investment at the Clonshaugh facility in Dublin, which encompasses two manufacturing facilities and the plc head office, will focus on expanding specialised manufacturing capability for new product development and the launch of new solid dose products currently in development. This facility plays a pivotal role in the delivery of Allergan’s global “Open Science” strategy by providing the critical small-scale pilot and manufacturing capability for Allergan’s important oral solid dosage product pipeline. It currently manufacturers products for the treatment of conditions including depression, irritable bowel syndrome, Alzheimer’s disease and hypertension.

Welcoming the investment, Martin Shanahan, CEO of IDA Ireland, said: “Allergan’s commitment to Ireland has been exemplary and we warmly welcome this continued growth and expansion in Westport and Dublin. This latest €65 million investment brings Allergan’s total investment in Ireland to in excess of €670 million, which is a considerable vote of confidence in Ireland as a place to do business and in the IDA’s regional development strategy. With a 40-year heritage in Ireland, Allergan’s broad geographical footprint in Ireland is a great example for other pharmaceutical firms considering locating here.  We wish Allergan continued success as a visionary leader delivering innovative and breakthrough treatments to the world from their strategic operations in Ireland.”

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4